用户名： 密码： 验证码：
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011
详细信息    查看全文
  • 作者：Patricia M Graves (1) (8)
    Leo Makita (2)
    Melinda Susapu (2) (3)
    Molly A Brady (4)
    Wayne Melrose (1)
    Corinne Capuano (4)
    Zaixing Zhang (3)
    Luo Dapeng (3)
    Masayo Ozaki (5) (9)
    David Reeve (1)
    Kazuyo Ichimori (6)
    Walter M Kazadi (3)
    Frederick Michna (1)
    Moses J Bockarie (7)
    Louise A Kelly-Hope (7)
  • 关键词：Lymphatic filariasis ; Papua New Guinea ; Mapping ; Mass drug administration
  • 刊名：Parasites & Vectors
  • 出版年：2013
  • 出版时间：December 2013
  • 年：2013
  • 卷：6
  • 期：1
  • 全文大小：578KB
  • 参考文献：1. Kazura JW, Bockarie MJ: Lymphatic filariasis in Papua New Guinea: interdisciplinary research on a national health problem. / Trends Parasitol 2003, 19:260-63. CrossRef
    2. Michael E, Bundy DA: Global mapping of lymphatic filariasis. / Parasitol Today 1997, 13:472-76. CrossRef
    3. Prybylski D, Alto WA, Mengeap S, Odaibaiyue S: Introduction of an integrated community-based bancroftian filariasis control program into the Mt Bosavi region of the Southern Highlands of Papua New Guinea. / PNG Med J 1994, 37:82-9.
    4. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW: Mass treatment to eliminate filariasis in Papua New Guinea. / N Engl J Med 2002, 347:1841-848. CrossRef
    5. Kazura JW, Bockarie M, Alexander N, Perry R, Bockarie F, Dagoro H, Dimber Z, Hyun P, Alpers MP: Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. / J Infect Dis 1997, 176:242-46. CrossRef
    6. Kazura J, Greenberg J, Perry R, Weil G, Day K, Alpers M: Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea. / Am J Trop Med Hyg 1993, 49:804-11.
    7. Tisch DJ, Bockarie MJ, Dimber Z, Kiniboro B, Tarongka N, Hazlett FE, Kastens W, Alpers MP, Kazura JW: Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. / Am J Trop Med Hyg 2008, 78:289-93.
    8. Burkot TR, Durrheim D, Melrose WD, Speare R, Ichimori K: The argument for integrating vector control with mass drug adminstration campaigns to ensure elimination of lymphatic filariasis. / Filaria J 2006, 5:10. CrossRef
    9. Bryan JH: Vectors of Wuchereria bancrofti in the Sepik Provinces of Papua New Guinea. / Trans R Soc Trop Med Hyg 1986, 80:123-31. CrossRef
    10. Bryan JH, Dagoro H, Southgate BA: Filarial vector studies in a diethylcarbamazine-treated and in untreated villages in Papua New Guinea. / J Trop Med Hyg 1995, 98:445-51.
    11. Iyengar MOT: / Distribution of filariasis in the South Pacific Region. pp. 52. Noumea: South Pacific Commission; 1954:52.
    12. van Dijk WJOM: The role of Culex fatigans in the transmission of Wuchereria bancrofti in New Guinea. / Trop Geogr Med 1965, 17:317-24.
    13. Webber RH: Vector control of filariasis in the Solomon Islands. / Southeast Asian J Trop Med Public Health 1975, 6:430-34.
    14. Iyengar MO, de Rook H, van Dyck WJOM: Interruption of transmission of Anopheles-borne filariasis by indoor residual spraying in Netherlands New Guinea. / Trop Geogr Med 1959, 11:287-90.
    15. Spencer M: The history of malaria control in the southwest Pacific region, with particular reference to Papua New Guinea and the Solomon Islands. / PNG Med J 1992, 35:33-6.
    16. Peters W: Studies on the epidemiology of malaria in New Guinea. Part III. Holoendemic malaria--analysis of data and relation to control. / Trans R Soc Trop Med Hyg 1960, 54:254-60. CrossRef
    17. Bockarie MJ, Pedersen EM, White GB, Michael E: Role of vector control in the global program to eliminate lymphatic filariasis. / Annu Rev Entomol 2009, 54:469-87. CrossRef
    18. Burkot TR, Garner P, Paru R, Dagoro H, Barnes A, McDougall S, Wirtz RA, Campbell G, Spark R: Effects of untreated bed nets on the transmission of Plasmodium falciparum, P. vivax and Wuchereria bancrofti in Papua New Guinea. / Trans R Soc Trop Med Hyg 1990, 84:773-79. CrossRef
    19. van den Berg H, Kelly-Hope L, Lindsay S: Malaria and lymphatic filariasis: the case for integrated vector management. / Lancet Inf Dis 2012,13(1):89-4. CrossRef
    20. Sapak P, Williams G: / Influence of bednets on LF in Buhutu valley. Pacific Health Dialog; 1997:4.
    21. Hetzel MW, Gideon G, Lote N, Makita L, Siba PM, Mueller I: Ownership and usage of mosquito nets after four years of large-scale free distribution in Papua New Guinea. / Malar J 2012, 11:192. CrossRef
    22. WHO: / The PacELF Way: Towards the elimination of lymphatic filariasis from the Pacific, 1999-005. Manila: WHO Western Pacific Region; 2006.
    23. WHO: / Preparing and implementing a national plan to eliminate lymphatic filariasis (in countries where onchocerciasis is not co-endemic. Geneva: World Health Organization; 2000.
    24. WHO: / Operational guidelines for rapid mapping of Bancroftian filariasis in Africa. Geneva: World Health Organization; 2000.
    25. WHO: / Global Programme to Eliminate Lymphatic Filariasis. Monitoring and Epidemiological Assessment of Mass Drug Administration. Geneva: World Health Organization; 2011.
    26. Gass K, de Rochars MV B, Boakye D, Bradley M, Fischer PU, Gyapong J, Itoh M, Ituaso-Conway N, Joseph H, Kyelem D, / et al.: A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. / PLoS Negl Trop Dis 2012, 6:e1479. journal.pntd.0001479">CrossRef
    27. Melrose WD, Turner PF, Pisters P, Turner B: An improved Knott’s concentration test for the detection of microfilariae. / Trans R Soc Trop Med Hyg 2000, 94:176. CrossRef
    28. WHO: / Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Geneva: World Health Organization; 2005.
    29. Weil GJ, Lammie PJ, Weiss N: The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. / Parasitol Today 1997, 13:401-04. CrossRef
    30. National, The (newspaper): PNGs new province Hela, Jiwaka declared. In / The National. Port Moresby, Papua New Guinea; 2012. http://www.thenational.com.pg
    31. NRI: / Papua New Guinea District and Provincial Profiles. Port Moresby, Papua New Guinea: National Research Institute; 2010.
    32. CIA: / World Factbook. Washington DC: Central Intelligence Agency; 2012.
    33. PNGDOH: / Papua New Guinea National Plan to Eliminate Lymphatic Filariasis 2004-020 (PNGELF). Port Moresby, Papua New Guinea: PNG Department of Health; 2007.
    34. WHO: / Regional Programme Managers Meeting on Lymphatic Filariasis and Other Selected Neglected Tropical Diseases. Manila, Philippines: WHO Western Pacific Region; 2011.
    35. Schuurkamp GJ, Kereu RK, Bulungol PK: Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1. / PNG Med J 1990, 33:89-8.
    36. Schuurkamp GJ, Kereu RK, Bulungol PK, Kawereng A, Spicer PE: Diethylcarbamazine in the control of bancroftian filariasis in the Ok Tedi area of Papua New Guinea: phase 2–annual single-dose treatment. / PNG Med J 1994, 37:65-1.
    37. Bockarie MJ, Tavul L, Ibam I, Kastens W, Hazlett F, Tisch DJ, Alpers MP, Kazura JW: Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. / Am J Trop Med Hyg 2007, 76:62-6.
    38. Bockarie M: Can lymphatic filariasis be eradicated in Papua New Guinea? / PNG Med J 1994, 37:61-4.
    39. Weil GJ, Kastens W, Susapu M, Laney SJ, Williams SA, King CL, Kazura JW, Bockarie MJ: The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. / PLoS Negl Trop Dis 2008, 2:e344. journal.pntd.0000344">CrossRef
    40. Mitja O, Paru R, Hays R, Griffin L, Laban N, Samson M, Bassat Q: The impact of a filariasis control program on Lihir Island, Papua New Guinea. / PLoS Negl Trop Dis 2011, 5:e1286. journal.pntd.0001286">CrossRef
    41. Tisch DJ, Michael E, Kazura JW: Mass chemotherapy options to control lymphatic filariasis: a systematic review. / Lancet Inf Dis 2005, 5:514-23. CrossRef
    42. WHO: / Global Programme to Eliminate Lymphatic Filariasis. Progress Report 2000-009 and Strategic Plan 2010-020. Geneva: WHO/HTM/NTD/PCT/ 2010.2016; 2010.
    43. Bockarie M, Tavul L, Kastens W, Michael E, Kazura JW: Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea. / Med Vet Entomol 2002, 16:116-19. j.0269-283x.2002.00352.x">CrossRef
    44. Sapak P, Williams G, Bryan J, Riley I: Efficacy of mass single-dose diethylcarbamazine and DEC-fortified salt against bancroftian filariasis in Papua New Guinea six months after treatment. / PNG Med J 2000, 43:213-20.
    45. Sapak P, Vallely A, Giuruna P, Maibani C: Diurnal subperiodic Bancroftian filariasis in Dogura, PNG. / Pacific Health Dialog 1998, 5:30-0.
    46. Sapak P, Melrose W, Durrheim D, Pawa F, Wynd S, Leggatt P, Taufa T, Bockarie M: / Evaluation of the lymphatic filariasis control program, Samurai Murua district. Papua New Guinea; 2004.
    47. Kombati Z: / Epidemiological aspects of Bancroftian filariasis in Lake Murray and Nomad areas of Western Province, Papua New Guinea. Townsville, Australia: PhD. James Cook University, School of Public Health and Tropical Medicine; 2001.
    48. Schuurkamp GJ: / The epidemiology of malaria and filariasis in the Ok Tedi region of Western Province, Papua New Guinea. PhD. Port Moresby, Papua New Guinea: University of Papua New Guinea; 1992.
    49. Turner PF: / Filariasis in the Western Province of Papua New Guinea. Townsville, Australia: PhD. James Cook University, Anton Breinl Centre for Tropical Health and Medicine; 1993.
    50. Hii J, Bockarie MJ, Flew S, Genton B, Tali A, Dagoro H, Waulas B, Samson M, Alpers MP: The epidemiology and control of lymphatic filariasis on Lihir Island, New Ireland Province. / PNG Med J 2000, 43:188-95.
    51. WHO: / WHO position statement: Integrated vector management to control malaria and lymphatic filariasis. Geneva: World Health Organization; 2011.
  • 作者单位：Patricia M Graves (1) (8)
    Leo Makita (2)
    Melinda Susapu (2) (3)
    Molly A Brady (4)
    Wayne Melrose (1)
    Corinne Capuano (4)
    Zaixing Zhang (3)
    Luo Dapeng (3)
    Masayo Ozaki (5) (9)
    David Reeve (1)
    Kazuyo Ichimori (6)
    Walter M Kazadi (3)
    Frederick Michna (1)
    Moses J Bockarie (7)
    Louise A Kelly-Hope (7)

    1. Department of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Cairns and Townsville, Queensland, Australia
    8. James Cook University, PO Box 6811, Cairns, Queensland, 4870, Australia
    2. Department of Health, Port Moresby, Papua New Guinea
    3. WHO, Port Moresby, Papua New Guinea
    4. WHO, Regional Office for the Western Pacific, Manila, Philippines
    5. WHO, Pacific Programme to Eliminate Lymphatic Filariasis (PacELF), Suva, Republic of Fiji
    9. University of Alabama School of Medicine, Birmingham, Alabama, USA
    6. WHO, Geneva, Switzerland
    7. Liverpool School of Tropical Medicine (LSTM), Centre for Neglected Tropical Diseases, Liverpool, United Kingdom of Great Britain and, Northern Ireland
文摘
Background Lymphatic filariasis (LF) caused by Wuchereria bancrofti is present at high prevalence in some parts of Papua New Guinea. However, there has been no rigorous data-based representative assessment of nationwide prevalence of LF. The LF programme has been daunted by the scope of the problem, and progress on mass drug administration (MDA) has been slow and lacking in resources. Methods A systematic literature review identified LF surveys in Papua New Guinea between 1980 and 2011. Results were extracted by location, time period and test used (blood slide, immunochromatographic test (ICT) or Og4C3 ELISA) and combined by district. Three criteria schemes based on the Global Programme to Eliminate Lymphatic Filariasis guidelines, with modifications, were developed to classify and prioritize districts by prevalence level. Results of repeated surveys in the same sites were used to investigate the impact of MDA on LF prevalence over the time period. Results There were 312 distinct survey sites identified in 80 of the 89 districts over the 31-year period. The overall LF prevalence in the sites tested was estimated at 18.5 to 27.5% by blood slide for microfilariae (Mf), 10.1% to 12.9% by ICT and 45.4% to 48.8% by Og4C3. Biases in site selection towards areas with LF, and change in type of assay used, affected the prevalence estimates, but overall decline in prevalence over the time period was observed. Depending on the criteria used, 34 to 36 districts (population 2.7 to 2.9 million) were classed as high endemic (?% prevalence), 15 to 25 districts (1.7 to 1.9 million) as low endemic (<5%) and 20 to 31 (1.3 to 2.2 million) as non-endemic. Nine districts (0.7 million) had no information. The strong impact of MDA, especially on microfilaria (Mf) prevalence, was noted in sites with repeat surveys. Conclusions This analytical review of past surveys of LF in Papua New Guinea enables better estimation of the national burden, identifies gaps in knowledge, quantifies and locates the population at risk, and can be used to predict the likely impact of MDA and/or vector control. Better targeting of districts by level of prevalence will strengthen the control programme, facilitate monitoring of the disease trend and increase the likelihood of reaching the target of LF elimination by 2020.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址：北京市海淀区学院路29号 邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700